News FDA approves Pfizer's Besponsa in aggressive blood cancer Besponsa becomes first of its kind indicated for rare type of acute lymphoblastic leukaemia.
News AZ and Merck & Co ovarian cancer drug gets expanded US use FDA approves Lynparza's use in a wider group of women.
News BMS shares fall after latest Opdivo disappointment BMS waiting for overall survival data of Opdivo and Yervoy in kidney cancer
News Biofrontera mulls US IPO to fund skin cancer drug German biotech Biofrontera is considering a US stock market listing to fund development and marketing of a skin cancer drug.
Views & Analysis Evolving immunotherapy strategies in NSCLC Status of immunotherapies in non-small cell lung cancer (NSCLC).
News Real world data essential for CAR-T therapy success Innovators will need to quantify value to bring costly drugs to market.
News AZ's ATR inhibitor ceralasertib flunks lung cancer test AstraZeneca has had a setback in its oncology pipeline, as AKT inhibitor ceralasertib fails to improve survival in a phase 3 lung cancer trial.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
